PRIMECAP MANAGEMENT CO/CA/ – BioMarin Pharmaceutical Inc. Transaction History
PRIMECAP MANAGEMENT CO/CA/ portfolio value:
$1.49B
portfolio value
PRIMECAP MANAGEMENT CO/CA/ quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.30% | -52.98K shares | 29.09M | $84.77 | 17.62M |
| Q2 2022 | share | Decrease | -0.57% | -100.98K shares | 94.21M | $82.87 | 17.67M |
| Q1 2022 | share | Decrease | -0.14% | -25.31K shares | -202.25M | $77.1 | 17.77M |
| Q4 2021 | share | Decrease | -0.74% | -132.55K shares | 186.67M | $89.08 | 17.80M |
| Q3 2021 | share | Decrease | -0.09% | -15.73K shares | -111.62M | $77.29 | 17.93M |
| Q2 2021 | share | Decrease | -1.13% | -204.72K shares | 126.90M | $83.44 | 17.95M |
| Q1 2021 | share | Increase | +0.05% | 9.83K shares | -220.3M | $75.51 | 18.15M |
| Q4 2020 | share | Decrease | -0.24% | -43.58K shares | 207.38M | $87.69 | 18.14M |
| Q3 2020 | share | Increase | +1.72% | 307.57K shares | -821.79M | $76.08 | 18.19M |
| Q2 2020 | share | Increase | +0.42% | 74.20K shares | 700.88M | $123.34 | 17.88M |
| Q1 2020 | share | Increase | +9.07% | 1.48M shares | 124.28M | $84.5 | 17.80M |
| Q4 2019 | share | Increase | +7.70% | 1.16M shares | 358.72M | $84.55 | 16.32M |
| Q3 2019 | share | Increase | +6.15% | 878.32K shares | -201.47M | $67.4 | 15.16M |
| Q2 2019 | share | Increase | +0.65% | 92.88K shares | -37.17M | $85.65 | 14.28M |
| Q1 2019 | share | Increase | +0.04% | 5.7K shares | 52.70M | $88.83 | 14.19M |
| Q4 2018 | share | Decrease | -0.16% | -23.31K shares | -169.93M | $85.15 | 14.18M |
| Q3 2018 | share | Decrease | -0.23% | -32.30K shares | 36.31M | $96.97 | 14.20M |
| Q2 2018 | share | Increase | +3.44% | 474.25K shares | 225.42M | $94.2 | 14.24M |
| Q1 2018 | share | Increase | +34.37% | 3.52M shares | 202.48M | $81.07 | 13.76M |
| Q4 2017 | share | Increase | +6.29% | 606.65K shares | 16.50M | $89.17 | 10.24M |
| Q3 2017 | share | Increase | +3.53% | 328.42K shares | 51.51M | $93.07 | 9.63M |
| Q2 2017 | share | Increase | +6.86% | 597.95K shares | 80.79M | $90.82 | 9.31M |
| Q1 2017 | share | Increase | +10.48% | 826.32K shares | 111.49M | $87.78 | 8.71M |
| Q4 2016 | share | Increase | +10.94% | 777.81K shares | -4.37M | $82.84 | 7.88M |
| Q3 2016 | share | Decrease | -2.89% | -211.19K shares | 88.20M | $92.52 | 7.10M |
| Q2 2016 | share | Decrease | -0.42% | -31.05K shares | -36.81M | $77.8 | 7.31M |
| Q1 2016 | share | Increase | +0.27% | 19.68K shares | -161.70M | $82.48 | 7.35M |